These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 12145740)
1. Reactivation of retinal toxoplasmosis despite evidence of immune response to highly active antiretroviral therapy. Stout JE; Lai JC; Giner J; Hamilton CD Clin Infect Dis; 2002 Aug; 35(4):e37-9. PubMed ID: 12145740 [TBL] [Abstract][Full Text] [Related]
2. Atypical toxoplasmic manifestation after discontinuation of maintenance therapy in a human immunodeficiency virus type 1-infected patient with immune recovery. Ghosn J; Paris L; Ajzenberg D; Carcelain G; Dardé ML; Tubiana R; Bossi P; Bricaire F; Katlama C Clin Infect Dis; 2003 Oct; 37(7):e112-4. PubMed ID: 13130422 [TBL] [Abstract][Full Text] [Related]
3. Discontinuation of secondary prophylaxis for toxoplasmic encephalitis in human immunodeficiency virus infection after immune restoration with highly active antiretroviral therapy. Guex AC; Radziwill AJ; Bucher HC Clin Infect Dis; 2000 Mar; 30(3):602-3. PubMed ID: 10722454 [No Abstract] [Full Text] [Related]
4. Toxoplasmosis in HIV/AIDS: a living legacy. Nissapatorn V Southeast Asian J Trop Med Public Health; 2009 Nov; 40(6):1158-78. PubMed ID: 20578449 [TBL] [Abstract][Full Text] [Related]
5. Strongyloidiasis in an HIV-1-infected patient after highly active antiretroviral therapy-induced immune restoration. Lanzafame M; Faggian F; Lattuada E; Antolini D; Vento S J Infect Dis; 2005 Mar; 191(6):1027. PubMed ID: 15717283 [No Abstract] [Full Text] [Related]
6. Incidence of acquired immunodeficiency syndrome-associated opportunistic diseases and the effect of treatment on a cohort of 1115 patients infected with human immunodeficiency virus, 1989-1997. San-Andrés FJ; Rubio R; Castilla J; Pulido F; Palao G; de Pedro I; Costa JR; del Palacio A Clin Infect Dis; 2003 May; 36(9):1177-85. PubMed ID: 12715314 [TBL] [Abstract][Full Text] [Related]
7. Toxoplasmosis-associated deaths among Human Immunodeficiency Virus-infected persons in the United States, 1992-1998. Jones JL; Sehgal M; Maguire JH Clin Infect Dis; 2002 Apr; 34(8):1161. PubMed ID: 11915013 [No Abstract] [Full Text] [Related]
8. Borderline tuberculoid leprosy with upgrading Type 1 reaction in a HIV seropositive patient, after antiretroviral therapy: an immune reconstitution inflammatory syndrome. Kar HK; Sharma P; Bhardwaj M Lepr Rev; 2009 Mar; 80(1):85-8. PubMed ID: 19472856 [TBL] [Abstract][Full Text] [Related]
9. Trends in opportunistic infections in the pre- and post-highly active antiretroviral therapy eras among HIV-infected children in the Perinatal AIDS Collaborative Transmission Study, 1986-2004. Nesheim SR; Kapogiannis BG; Soe MM; Sullivan KM; Abrams E; Farley J; Palumbo P; Koenig LJ; Bulterys M Pediatrics; 2007 Jul; 120(1):100-9. PubMed ID: 17606567 [TBL] [Abstract][Full Text] [Related]
10. Immune reconstitution inflammatory syndrome among HIV/AIDS patients during highly active antiretroviral therapy in Addis Ababa, Ethiopia. Huruy K; Mulu A; Mengistu G; Shewa-Amare A; Akalu A; Kassu A; Andargie G; Elias D; Torben W Jpn J Infect Dis; 2008 May; 61(3):205-9. PubMed ID: 18503170 [TBL] [Abstract][Full Text] [Related]
11. [Highly Active AntiRetroviral Therapy and opportunistic protozoan infections]. Pozio E Parassitologia; 2004 Jun; 46(1-2):89-93. PubMed ID: 15305694 [TBL] [Abstract][Full Text] [Related]
12. The rate of serious bacterial infections among HIV-infected children with immune reconstitution who have discontinued opportunistic infection prophylaxis. Nachman S; Gona P; Dankner W; Weinberg A; Yogev R; Gershon A; Rathore M; Read JS; Huang S; Elgie C; Hudgens K; Hughes W Pediatrics; 2005 Apr; 115(4):e488-94. PubMed ID: 15772172 [TBL] [Abstract][Full Text] [Related]
14. Discontinuation of secondary prophylaxis for cryptococcal meningitis in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy: a prospective, multicenter, randomized study. Vibhagool A; Sungkanuparph S; Mootsikapun P; Chetchotisakd P; Tansuphaswaswadikul S; Bowonwatanuwong C; Ingsathit A Clin Infect Dis; 2003 May; 36(10):1329-31. PubMed ID: 12746781 [TBL] [Abstract][Full Text] [Related]
15. Immune reconstitution disease associated with parasitic infections following initiation of antiretroviral therapy. Lawn SD Curr Opin Infect Dis; 2007 Oct; 20(5):482-8. PubMed ID: 17762781 [TBL] [Abstract][Full Text] [Related]
16. Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS. Posada-Vergara MP; Lindoso JA; Tolezano JE; Pereira-Chioccola VL; Silva MV; Goto H J Infect Dis; 2005 Nov; 192(10):1819-22. PubMed ID: 16235183 [TBL] [Abstract][Full Text] [Related]
17. Improvement of symptomatic human immunodeficiency virus-related lymphoid interstitial pneumonia in patients receiving highly active antiretroviral therapy. Dufour V; Wislez M; Bergot E; Mayaud C; Cadranel J Clin Infect Dis; 2003 May; 36(10):e127-30. PubMed ID: 12746792 [TBL] [Abstract][Full Text] [Related]
18. Immune reconstitution syndrome following initiation of antiretroviral therapy in a patient with HIV infection and multidrug-resistant tuberculosis. Swaminathan S; Padmapriyadarsini C; Narendran G; Thomas BE; Anand S; Rajyalakshmi A Indian J Chest Dis Allied Sci; 2005; 47(4):299-304. PubMed ID: 16255403 [TBL] [Abstract][Full Text] [Related]